Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

The clinical stage biopharmaceutical company is developing inhaled drug delivery devices. Transpire Bio expands headquarters ...

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Glenmark Pharma continued to benefit from its strong position in key chronic therapy areas, including respiratory and dermatology therapeutics, according to its latest, opens new tab annual report.

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...